Table 3. LA structure and function in healthy volunteers and AF patients.
LA parameters | Total AF Patients (n=90) | Healthy Volunteers (n=14) | P Value |
---|---|---|---|
|
|
|
|
LA mild enhancement (%) | 31 ± 13.8 | 8.9 ± 6.0 * | <0.001 |
LA dense enhancement (%) | 7.1 ± 5.9 | 0.1 ± 0.5¶ | <0.001 |
LA Wall Thickness | 2.06 ± 0.32 | 2.15 ± 0.30 | 0.308 |
LAVImax (ml/m2) | 52 ± 15 | 36 ± 10 | <0.001 |
LAVImin (ml/m2) | 31 ± 13 | 18 ± 6 | <0.001 |
LAPEF (%) | 19 ± 7 | 24 ± 6 | 0.002 |
LAAEF (%) | 23 ± 8 | 34 ± 10 | <0.001 |
PALS (%) | 22 ± 8 | 33 ± 9 | <0.001 |
SR-s (1/s) | 0.93 ± 0.36 | 1.39 ± 0.48 | <0.001 |
SR-ed (1/s) | 0.82 ± 0.39 | 1.1 ± 0.40 | 0.01 |
SR-ld (1/s) | 1.07 ± 0.57 | 1.75 ± 0.89 | <0.001 |
Abbreviations as in Table 2.
LA fibrosis was present in 12 patients.
Only one patient had 2% of scar